Sign in Subscribe

Latest

Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

Oculis raises $57m Series C led by BVCF Management and Hyfinity Investments

Iceland founded Oculis Pharma has closed an oversubscribed $57 million Series C financing. Oculis said in a press release that the proceeds from the financing will accelerate the company’s strategy with the aim of delivering key goals in the near future to drive shareholder value and bring transformative therapies

Vista Data Vision acquired by Bentley Systems for an undisclosed amount

Vista Data Vision acquired by Bentley Systems for an undisclosed amount

Vista Data Vision, a Reykjavík based software company specializing in data monitoring systems, has been acquired by Bentley Systems Inc., an infrastructure engineering software company listed on the NASDAQ stock exchange. The acquisition was announced on April 29. Vista Data Vision is a second-generation family business spun out of Vista

Hefring raises an undisclosed amount in a financing round led by The New Business Venture Fund

Hefring raises an undisclosed amount in a financing round led by The New Business Venture Fund

The start-up company Hefring Marine has closed a financing round led by the New Business Venture Fund (Nýsköpunarsjóður atvinnulífsins). Two other funds invested in this round, the German fund Innoport and the American fund TechNexus. The New Business Venture Fund acquired a quarter of Hefring when the fund first invested

Icelandic Startups & Tech Roundup on April 27

Icelandic Startups & Tech Roundup on April 27

We have decided to start collecting the news you might have missed from the Icelandic startup ecosystem in the last week or so, delivering them to you on a regular basis. Here’s what’s been happening lately: Carbfix to open up a plant Carbfix, a company which has developed

EpiEndo receives €2.7m from the European Innovation Council Fund

EpiEndo receives €2.7m from the European Innovation Council Fund

EpiEndo Pharmaceuticals, an Icelandic clinical-stage biopharmaceutical company developing novel non-antibiotic macrolide therapeutics for the treatment of inflammatory disorders, announced last week that it was a recipient of a €2.7m convertible loan agreement from the European Innovation Council Fund. The Fund was created by the European Commission last year, and

Ásthildur Otharsdóttir joins Frumtak Ventures as partner

Ásthildur Otharsdóttir joins Frumtak Ventures as partner

Ásthildur Otharsdóttir has become a new partner of the Icelandic investment company Frumtak Ventures, which manages the VC funds Frumtak I and Frumtak II. This was announced in a press release by Frumtak earlier today. According to the press release, Ásthildur will – along with the company’s current partners, Eggert

Estonian investors encourage Icelanders to take a look at Funderbeam

A director at Funderbeam, an online fundraising platform which some Icelandic companies have used, says that it has sparked some attention how limited the participation of Icelandic investors is on the platform. Morgunblaðið, an Icelandic daily, spoke to Runno Allikivi, which leads Funderbeam in the Nordics, earlier this week. He